TransMedics Group, Inc. TMDX
85.29
1.39
1.66%
as of 25 Sep
- Market cap
- $2.9B
- P/E
- 19.3×
Follow TMDX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
32.48% | 54.24% | 45.22% | 36.28% | |
| 10.60% | 20.33% | 15.13% | 12.88% | ||
ROIC |
14.97% | 13.65% | 6.64% | 5.62% | |
Return on Tangible Assets |
10.84% | 21.72% | 19.34% | 16.52% | |
Average Days of Receivables |
52.01 | 50.81 | 52.08 | 56.86 | |
Free Cash Flow per Share |
3.54 | 3.93 | 4.40 | 2.29 | |
Free Cash Flow |
120.65 | 133.59 | 151.36 | 79.04 | |
Capital Expenditures |
(57.34) | (59.25) | (68.87) | (66.89) | |
Piotroski F-Score |
7.00 | 7.00 | 5.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
13.35% | 13.08% | 12.15% | 7.88% | |
Accounts Receivable Turnover |
6.63 | 6.65 | 5.46 | 6.40 | |
Accounts Payable Turnover |
17.79 | 23.51 | 23.93 | 24.60 | |
Inventory Turnover |
4.65 | 5.09 | 5.58 | 5.94 | |
Average Days of Payables |
19.73 | 15.57 | 15.65 | 17.06 | |
Days of Inventory on Hand |
72.22 | 73.52 | 70.00 | 71.56 | |
Tax Rate |
(0.01) | 0.77 | 0.92 | 1.09 | |
Research and Development Expense of Revenue |
11.44% | 11.40% | 12.07% | 13.83% | |
Selling, General and Administrative Expense of Revenue |
31.89% | 30.58% | 32.16% | 32.65% | |
Share Based Compensation of Revenue |
6.75% | 6.09% | 5.95% | 5.55% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.94 | 1.01 | 1.28 | 0.96 | |
Depreciation/Fixed assets |
0.08 | 0.08 | 0.09 | 0.10 | |
Capex/Depreciation |
(2.26) | (2.18) | (2.09) | (1.84) | |
Revenue per Share |
16.60 | 17.81 | 18.49 | 19.33 | |
Operating CF per Share |
5.22 | 5.67 | 6.40 | 4.22 | |
Capex per Share |
(1.68) | (1.74) | (2.00) | (1.93) | |
Capex to Sales |
0.10 | 0.10 | 0.11 | 0.10 | |
Net Profit Margin |
16.20% | 31.43% | 27.04% | 22.69% |
Columns are period end dates